$ICUI
ICU MEDICAL INC/DE Stock $icui

$icui Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-Q Financial Statement

#000088398416000077 Filed on August 09, 2016

Income Statement

Concept	2016 Q2	2015 Q2
Revenue	$96.72M	$83.78M
YoY Change	15.45%	6.49%
Cost Of Revenue	$46.59M	$40.02M
YoY Change	16.41%	-2.71%
Gross Profit	$50.13M	$43.76M
YoY Change	14.56%	16.57%
Gross Profit Margin	51.83%	52.23%
Selling, General & Admin	$22.49M	$20.32M
YoY Change	10.69%	-16.31%
% of Gross Profit	44.86%	46.43%
Research & Development	$3.338M	$3.122M
YoY Change	6.92%	-31.63%
% of Gross Profit	6.66%	7.13%
Depreciation & Amortization	$4.800M	$4.400M
YoY Change	9.09%	-10.2%
% of Gross Profit	9.57%	10.05%
Operating Expenses	$27.36M	$23.44M
YoY Change	16.73%	-18.74%
Operating Profit	$22.77M	$20.32M
YoY Change	12.05%	133.63%
Interest Expense	$48.00K
YoY Change
% of Operating Profit	0.21%
Other Income/Expense, Net	$125.0K	$240.0K
YoY Change	-47.92%	15.94%
Pretax Income	$23.96M	$20.56M
YoY Change	16.52%	130.89%
Income Tax	$7.351M	$6.991M
% Of Pretax Income	30.68%	34.0%
Net Earnings	$16.61M	$13.57M
YoY Change	22.37%	130.86%
Net Earnings / Revenue	17.17%	16.2%
Basic Earnings Per Share	$1.03	$0.86
Diluted Earnings Per Share	$0.98	$0.83
COMMON SHARES
Basic Shares Outstanding	16.09M shares	15.78M shares
Diluted Shares Outstanding	17.00M shares	16.35M shares

Balance Sheet

Concept	2016 Q2	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$400.6M	$367.3M
YoY Change	9.07%	16.31%
Cash & Equivalents	$372.9M	$331.1M
Short-Term Investments	$27.70M	$36.20M
Other Short-Term Assets	$12.30M	$13.80M
YoY Change	-10.87%	22.12%
Inventory	$49.92M	$38.23M
Prepaid Expenses
Receivables	$60.49M	$43.43M
Other Receivables	$12.10M	$8.300M
Total Short-Term Assets	$535.4M	$471.1M
YoY Change	13.66%	14.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$79.70M	$81.38M
YoY Change	-2.05%	-11.45%
Goodwill	$6.245M	$1.478M
YoY Change	322.53%	0.0%
Intangibles	$23.18M	$6.415M
YoY Change	261.39%	-16.34%
Long-Term Investments
YoY Change
Other Assets	$18.90M	$9.900M
YoY Change	90.91%	70.69%
Total Long-Term Assets	$128.0M	$99.19M
YoY Change	29.04%	-7.19%
TOTAL ASSETS
Total Short-Term Assets	$535.4M	$471.1M
Total Long-Term Assets	$128.0M	$99.19M
Total Assets	$663.4M	$570.2M
YoY Change	16.33%	9.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.85M	$12.59M
YoY Change	49.78%	11.11%
Accrued Expenses	$21.76M	$16.09M
YoY Change	35.23%	1.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$40.61M	$28.68M
YoY Change	41.62%	5.72%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.800M	$1.200M
YoY Change	133.33%	-55.56%
Total Long-Term Liabilities	$2.800M	$1.200M
YoY Change	133.33%	-55.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$40.61M	$28.68M
Total Long-Term Liabilities	$2.800M	$1.200M
Total Liabilities	$47.20M	$32.20M
YoY Change	46.58%	-5.57%
SHAREHOLDERS EQUITY
Retained Earnings	$488.7M	$432.2M
YoY Change	13.07%	9.38%
Common Stock	$151.0M	$123.7M
YoY Change	22.07%	37.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$4.471M
YoY Change
Treasury Stock Shares	50.00K shares
Shareholders Equity	$616.2M	$538.1M
YoY Change
Total Liabilities & Shareholders Equity	$663.4M	$570.2M
YoY Change	16.33%	9.76%

Cashflow Statement

Concept	2016 Q2	2015 Q2
OPERATING ACTIVITIES
Net Income	$16.61M	$13.57M
YoY Change	22.37%	130.86%
Depreciation, Depletion And Amortization	$4.800M	$4.400M
YoY Change	9.09%	-10.2%
Cash From Operating Activities	$24.50M	$15.90M
YoY Change	54.09%	-4.22%
INVESTING ACTIVITIES
Capital Expenditures	-$5.400M	-$2.800M
YoY Change	92.86%	-60.56%
Acquisitions
YoY Change
Other Investing Activities	$6.400M	$9.900M
YoY Change	-35.35%	-335.71%
Cash From Investing Activities	$800.0K	$7.100M
YoY Change	-88.73%	-162.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.400M	-2.000M
YoY Change	-220.0%	-154.05%
NET CHANGE
Cash From Operating Activities	24.50M	15.90M
Cash From Investing Activities	800.0K	7.100M
Cash From Financing Activities	2.400M	-2.000M
Net Change In Cash	27.70M	21.00M
YoY Change	31.9%	133.33%
FREE CASH FLOW
Cash From Operating Activities	$24.50M	$15.90M
Capital Expenditures	-$5.400M	-$2.800M
Free Cash Flow	$29.90M	$18.70M
YoY Change	59.89%	-21.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	icui	Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute. Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute.	7059000	USD
	icui	Operating Financingcashflowimpactof Asu201609 OperatingFinancingcashflowimpactofASU201609	3400000	USD
	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	38000	USD
	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	-125000	USD
	icui	Total Restructuring Charges TotalRestructuringCharges	400000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000883984
CY2016Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16132041	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	ICU MEDICAL INC/DE
	icui	Bargainpurchasegainnoncashaddback Bargainpurchasegainnoncashaddback	0	USD
	icui	Bargainpurchasegainnoncashaddback Bargainpurchasegainnoncashaddback	1110000	USD
	icui	Debt Securities Maturity Date Range High DebtSecuritiesMaturityDateRangeHigh	2036
	icui	Debt Securities Maturity Date Range Low DebtSecuritiesMaturityDateRangeLow	2016
CY2016Q2	icui	Dilutivesecuritiesadjustmentfrom Asu201609 DilutivesecuritiesadjustmentfromASU201609	345000	shares
	icui	Dilutivesecuritiesadjustmentfrom Asu201609 DilutivesecuritiesadjustmentfromASU201609	340000	shares
CY2016Q2	icui	Incometaxexcesstaxbenefitadjustment Asu201609 Adoption IncometaxexcesstaxbenefitadjustmentASU201609Adoption	800000	USD
	icui	Incometaxexcesstaxbenefitadjustment Asu201609 Adoption IncometaxexcesstaxbenefitadjustmentASU201609Adoption	3100000	USD
	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	-2031000	USD
	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	4793000	USD
CY2015Q2	icui	Legalsettlementaccrual Legalsettlementaccrual	7100000	USD
	icui	Legalsettlementcharge Legalsettlementcharge	6500000	USD
	icui	Operating Financingcashflowimpactof Asu201609 OperatingFinancingcashflowimpactofASU201609	3100000	USD
CY2016Q2	icui	Treasury Stock Purchase Plan TreasuryStockPurchasePlan	40000000	USD
CY2016Q2	icui	Treasury Stock Purchase Plan Remaining Available TreasuryStockPurchasePlanRemainingAvailable	7200000	USD
CY2015Q2	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	0	USD
	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	0	USD
CY2016Q2	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	1533000	USD
	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	1533000	USD
	icui	Strategic Transaction Costs StrategicTransactionCosts	1100000	USD
CY2016Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	60487000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	28948000	USD
CY2016Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	21759000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	148728000	USD
CY2015Q2	icui	Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute. Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute.	0	USD
	icui	Paymentsfor Repurchaseof Equityincludingcommissions PaymentsforRepurchaseofEquityincludingcommissions	15400000	USD
CY2016Q2	icui	Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute. Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute.	0	USD
	icui	Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute. Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute.	0	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	13670000	USD
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	18853000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	57847000	USD
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	157510000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-20758000	USD
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-18926000	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	145125000	USD
CY2016Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	149344000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1101000	USD
CY2016Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1114000	USD
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	33000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	16000	shares
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4300	shares
CY2015Q4	us-gaap	Assets Assets	626825000	USD
CY2016Q2	us-gaap	Assets Assets	663379000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	505007000	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	535394000	USD
CY2015Q4	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	4134000	USD
CY2016Q2	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	4209000	USD
CY2015Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	4134000	USD
CY2016Q2	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	4209000	USD
CY2016Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	41233000	USD
CY2016Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	27720000	USD
	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0	USD
CY2015Q2	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	USD
	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	USD
CY2016Q2	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	1110000	USD
	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	1110000	USD
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	2600000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	232000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1574000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	275812000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	331092000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	336164000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	372895000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	55280000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	36731000	USD
CY2015Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	377397000	USD
CY2016Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	400615000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15595000	shares
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	766000	USD
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16175000	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15595000	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16125000	shares
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	36598000	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	1608000	USD
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	1618000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	15438000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	15033000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	14339000	USD
CY2015Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	6003000	USD
CY2016Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	10918000	USD
CY2015Q4	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	USD
CY2016Q2	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	USD
CY2015Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	40020000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	78990000	USD
CY2016Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	46589000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	87211000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	17099000	USD
CY2016Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	18853000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1372000	USD
CY2016Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	3764000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9026000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9648000	USD
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.86
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.48
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.16
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.83
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.43
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.98
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.05
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-6350000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1445000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.27
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2015Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	3638000	USD
CY2016Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	3919000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	33000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-31000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	6463000	USD
CY2016Q2	us-gaap	Goodwill Goodwill	6245000	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	43761000	USD
	us-gaap	Gross Profit GrossProfit	86275000	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	50132000	USD
	us-gaap	Gross Profit GrossProfit	99365000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	20561000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	32060000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	23957000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	48049000	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6991000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8804000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7351000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13283000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1894000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3752000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5529000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2527000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1027000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5985000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2267000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5479000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1375000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3784000	USD
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	571000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	564000	shares
CY2016Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	909000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	894000	shares
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	23936000	USD
CY2016Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	23183000	USD
CY2015Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	14669000	USD
CY2016Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	18396000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	43632000	USD
CY2016Q2	us-gaap	Inventory Net InventoryNet	49919000	USD
CY2015Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	24681000	USD
CY2016Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	27265000	USD
CY2015Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	4282000	USD
CY2016Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	4258000	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	1223000	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	121000	USD
	us-gaap	Legal Fees LegalFees	700000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	626825000	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	663379000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	42618000	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	40612000	USD
CY2015Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	1476000	USD
CY2016Q2	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	1288000	USD
CY2015Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	1488000	USD
CY2016Q2	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	1488000	USD
CY2015Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	96909000	USD
CY2016Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	99259000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5403000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7918000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	27052000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1429000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	29175000	USD
	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	17661	shares
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	41775000	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	240000	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	77000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	224000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	23440000	USD
	us-gaap	Operating Expenses OperatingExpenses	54981000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	27362000	USD
	us-gaap	Operating Expenses OperatingExpenses	52650000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	20321000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	31294000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	22770000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	46715000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1868000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-8223000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2267000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1832000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	508000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-2212000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-746000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	413000	USD
	us-gaap	Other Restructuring Costs OtherRestructuringCosts	200000	USD
CY2015Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	119000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	280000	USD
CY2016Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	9000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	15000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1435000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	16911000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	3629000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1600000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2606000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	440000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	513000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	17092000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	18106000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5005000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9112000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2016Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7796000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	34000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5797000	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7631000	USD
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8092000	USD
CY2015Q4	us-gaap	Prepaid Taxes PrepaidTaxes	14366000	USD
CY2016Q2	us-gaap	Prepaid Taxes PrepaidTaxes	12072000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	49555000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	31765000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1041000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1197000	USD
CY2015Q2	us-gaap	Profit Loss ProfitLoss	13570000	USD
	us-gaap	Profit Loss ProfitLoss	23256000	USD
CY2016Q2	us-gaap	Profit Loss ProfitLoss	16606000	USD
	us-gaap	Profit Loss ProfitLoss	34766000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	223048000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	237214000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	74320000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	79704000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	53000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3122000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7430000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3338000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6651000	USD
	us-gaap	Restructuring Charges RestructuringCharges	193000	USD
CY2015Q4	us-gaap	Restructuring Reserve RestructuringReserve	6539000	USD
CY2016Q2	us-gaap	Restructuring Reserve RestructuringReserve	3229000	USD
	us-gaap	Restructuring Reserve Accrual Adjustment RestructuringReserveAccrualAdjustment	0	USD
	us-gaap	Restructuring Reserve Translation Adjustment RestructuringReserveTranslationAdjustment	126000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	453896000	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	488662000	USD
CY2015Q2	us-gaap	Revenues Revenues	83781000	USD
	us-gaap	Revenues Revenues	165265000	USD
CY2016Q2	us-gaap	Revenues Revenues	96721000	USD
	us-gaap	Revenues Revenues	186576000	USD
CY2015Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	83662000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	164985000	USD
CY2016Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	96712000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	186561000	USD
CY2015Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20318000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	40492000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22491000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	44466000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5947000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	7674000	USD
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	174885	shares
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	579871000	USD
CY2016Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	616227000	USD
CY2015Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2016Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	50000	shares
CY2015Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2016Q2	us-gaap	Treasury Stock Value TreasuryStockValue	4471000	USD
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16352000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16302000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16964000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15781000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15738000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16091000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16070000	shares
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Issued Accounting Standards</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This update amends the FASB's guidance on the impairment of financial instruments by requiring timelier recording of credit losses on loans and other financial instruments. The ASU adds an impairment model that is based on expected losses rather than incurred losses. The ASU also amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. The amendments in this update will be effective for fiscal years beginning after December 15, 2019. Early adoption is permitted as of the fiscal years beginning after December 15, 2018. The updated guidance requires a modified retrospective adoption. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). The amendments in this update require an entity to recognize a right-of-use asset and lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification as finance or operating lease. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. The amendments in this update will be effective for fiscal years beginning after December 15, 2019. Early adoption is permitted. The updated guidance requires a modified retrospective adoption. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2016, the FASB issued ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, which amends certain aspects of recognition, measurement, presentation and disclosure of financial instruments. This amendment requires all equity investments to be measured at fair value with changes in the fair value recognized through net income (other than those accounted for under the equity method of accounting or those that result in the consolidation of the investee). The amendments in this update will be effective for fiscal years beginning after December 15, 2017. Early adoption of the amendments is not permitted with the exception of the provision requiring the recognition in other comprehensive income the fair value change from instrument-specific credit risk measured using the fair value option for financial instruments. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures. </font></div><div style="line-height:120%;text-align:left;text-indent:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">        </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2015, the FASB issued ASU No. 2015-11 Inventory (Topic 330): Simplifying the Measurement of Inventory. ASU 2015-11 changes the measurement of inventory from lower of cost or market to lower of cost and net realizable value. The amendments are effective prospectively for the fiscal years, and interim reporting periods within those years, beginning on or after December 15, 2016. We do not anticipate a material impact on our consolidated financial statements from the adoption of this ASU.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). ASU 2014-09 removes inconsistencies and weaknesses in revenue requirements, provides a more robust framework for addressing revenue issues, improves comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets, provides more useful information to users of financial statements through improved disclosure requirements and simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. This guidance requires that an entity depict the consideration by applying a five-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. On April 1, 2015, the FASB voted for a one-year deferral of the effective date of the new revenue recognition standard, ASU No. 2014-09.  On July 15, 2015, the FASB affirmed these changes, which requires public entities to apply the amendments in ASU 2014-09 for annual reporting beginning after December 15, 2017. Early adoption is permitted beginning after December 31, 2016, the original effective date in ASU 2014-09. Subsequent to the issuance of this ASU, the FASB issued three amendments: ASU No. 2016-08 which clarifies principal versus agent considerations; ASU No. 2016-10 which clarifies guidance related to identifying performance obligations and licensing implementation; and ASU 2016-12 which provides narrow-scope improvements and practical expedients. All of the amendments have the same effective dates mentioned above. We do not anticipate a material impact on our consolidated financial statements from adoption of any of the above ASUs. We expect to adopt the full retrospective transition method when adopting this ASU.</font></div></div>

Files In Submission

Name	View Source	Status
0000883984-16-000077-index-headers.html	Edgar Link	pending
0000883984-16-000077-index.html	Edgar Link	pending
0000883984-16-000077.txt	Edgar Link	pending
0000883984-16-000077-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
icui-20160630.xml	Edgar Link	completed
icui-20160630.xsd	Edgar Link	pending
icui-20160630_cal.xml	Edgar Link	unprocessable
icui-20160630_def.xml	Edgar Link	unprocessable
icui-20160630_lab.xml	Edgar Link	unprocessable
icui-20160630_pre.xml	Edgar Link	unprocessable
icui-ex311_20160630x10q.htm	Edgar Link	pending
icui-ex312_x20160630x10q.htm	Edgar Link	pending
icui-ex321_x20160630x10q.htm	Edgar Link	pending
icui0630201610-q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICUI
ICU MEDICAL INC/DE Stock $icui

2016 Q2 Form 10-Q Financial Statement

#000088398416000077 Filed on August 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI ICU MEDICAL INC/DE Stock $icui

2016 Q2 Form 10-Q Financial Statement

#000088398416000077 Filed on August 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI
ICU MEDICAL INC/DE Stock $icui